Page last updated: 2024-10-31

minaprine and Dementia

minaprine has been researched along with Dementia in 1 studies

minaprine: Agr 1240 refers to di-HCl; short-acting type A MAO inhibitor (MAOI) of mild potency; structure

Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Passeri, M1
Cucinotta, D1
de Mello, M1
Storchi, G1
Roncucci, R1
Bizière, K1

Trials

1 trial available for minaprine and Dementia

ArticleYear
Minaprine for senile dementia.
    Lancet (London, England), 1985, Apr-06, Volume: 1, Issue:8432

    Topics: Aged; Alzheimer Disease; Clinical Trials as Topic; Dementia; Humans; Middle Aged; Pyridazines

1985